BROOKE OTREMBA: Open Payments
NPI 1043998156 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $990 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $177 |
| Axsome Therapeutics, Inc. | 3 | $158 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Corium, LLC | 8 | $84 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: Auvelity, FANAPT, LYBALVI, Azstarys, ARISTADA, VRAYLAR, Qelbree, Jornay PM.
Industry payments across LA — which companies pay providers there.
